Tracy Weslosky, Editor-in-Chief and Publisher of InvestorIntel speaks to Ron Tremblay, the CEO, President and Director for Levon Resources, about Levons investment in the new SciVac Therapeutics Inc. Levon, which has a poly-metallic flagship silver, gold, lead and zinc Cordero project in Mexico, discusses how the investment in Pershing Gold, lead to the investment in a hepatitis vaccine. He says when asked about the leap from resources to biotech: Thats how people get rich is by doing deals that are out of the box instead of doing the same thing as everyone else.